ENUREV

This brand name is authorized in Austria, Estonia, Spain, Croatia, Ireland, Italy, Lithuania, Poland, South Africa

Active ingredients

The drug ENUREV contains one active pharmaceutical ingredient (API):

1 Glycopyrronium bromide UNII A14FB57V1D - GLYCOPYRRONIUM

Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways. Read about Glycopyrronium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BB06		R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1595875, 1595886, 1595897, 1595909, 1595910, 1595921, 1718490
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 112789003
Country: IT	Agenzia del Farmaco	Identifier(s): 042304016, 042304028, 042304030, 042304042, 042304055, 042304067, 042304079, 042304081
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067952, 1067953, 1067954, 1067955, 1067956, 1067957, 1076816, 1076817
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100309639
Country: ZA	Health Products Regulatory Authority	Identifier(s): 47/10.2.1/0119